Filters

See more specimen types...
See more states

Other countries

Results: 1 to 20 of 70

Tests names and labsConditionsGenes and analytesMethods

CentoCancer panel

Centogene AG - the Rare Disease Company
Germany
5231
  • C Sequence analysis of the entire coding region

Rapid microarray (CGH and SNP)

Allele Diagnostics
United States
247231
  • H Detection of homozygosity
  • D Deletion/duplication analysis
  • H Detection of homozygosity

Li-Fraumeni syndrome type 1

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Li-Fraumeni Syndrome (P53)

Center for Genetics at Saint Francis Saint Francis Hospital
United States
11
  • C Sequence analysis of the entire coding region

Colorectal Cancer NextGen Sequencing (NGS) And Deletion/Duplication Panel

PreventionGenetics
United States
2117
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

TP53. Complete sequencing

Instituto de Medicina Genomica
Spain
11
  • C Sequence analysis of the entire coding region

Pancreatic Cancer NextGen Sequencing (NGS) Panel

PreventionGenetics
United States
1312
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Cancer NextGen Sequencing (NGS) Panel

PreventionGenetics
United States
4335
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Renal Cancer NextGen Sequencing (NGS) Panel

PreventionGenetics
United States
2619
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

MitoMet®Plus aCGH Analysis

Baylor Miraca Genetics Laboratories
United States
845637
  • D Deletion/duplication analysis

TP53 Sequence Analysis (Familial Mutation/Variant Analysis)

Baylor Miraca Genetics Laboratories
United States
91
  • T Targeted variant analysis

TP53 Sequence Analysis

Baylor Miraca Genetics Laboratories
United States
91
  • C Sequence analysis of the entire coding region

TP53 Deletion/Duplication Analysis

Baylor Miraca Genetics Laboratories
United States
91
  • D Deletion/duplication analysis

TP53 Comprehensive - Sequence & Deletion/Duplication Analysis

Baylor Miraca Genetics Laboratories
United States
91
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Li-Fraumeni Syndrome via the TP53 Gene

PreventionGenetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

nucSEEK® Comprehensive Sequence Analysis Of The Nuclear Mitochondrial Exome

Courtagen Diagnostics Laboratory Courtagen Life Sciences
United States
560420
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Brain Tumor Panel

Division of Genomic Diagnostics The Children's Hospital of Philadelphia
United States
1917
  • S Mutation scanning of the entire coding region

Hereditary Prostate Cancer Panel

Division of Genomic Diagnostics The Children's Hospital of Philadelphia
United States
45
  • S Mutation scanning of the entire coding region

Hereditary Pancreatic Cancer Panel

Division of Genomic Diagnostics The Children's Hospital of Philadelphia
United States
2118
  • S Mutation scanning of the entire coding region

CHOP Comprehensive Hereditary Cancer Panel

Division of Genomic Diagnostics The Children's Hospital of Philadelphia
United States
92128
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 70

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.